Headshot photo of Laura Wilsey, Ph.D.

Laura Wilsey, Ph.D.

  • Senior Research Associate, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Biography

Laura Wilsey received her Ph. D. in Biophysics while investigating homocysteine thiolactone’s role in the carboxylation of the ryanodine receptor found in both skeletal and cardiac muscle. Afterwards she went to work with the Discoveries in Sight research team at Devers Eye Institute focusing on early detection of glaucoma. There, as a staff scientist, her goals where to link multiple in vivo imaging techniques (Optical Coherence Tomography, Confocal Scanning Laser Ophthalmoscopy, ect) with scanning laser confocal microscopy and correlate those with high-resolution Electron Microscopy. Laura is currently working on expanding imaging pipelines from sample preparation to imaging and prost processing of 2- and 3- dimensional light and electron microscopy datasets.

Education and training

Memberships and associations:

  • Biophysical Society
  • Microscopy Society of America
  • Microanalysis Society of America

Publications

Selected publications

  • Liu G, Li H, Cull G, Wilsey L, Yang H, Reemmer J, Shen HY, Wang F, Fortune B, Bui BV, Wang L. Downregulation of Retinal Connexin 43 in GFAP-Expressing Cells Modifies Vasoreactivity Induced by Perfusion Ocular Pressure Changes. Invest Ophthalmol Vis Sci. 2021 Jan 4;62(1):26. doi: 10.1167/iovs.62.1.26. PubMed PMID: 33502459; PubMed Central PMCID: PMC7846954.
  • Wilsey L, Gowrisankaran S, Cull G, Hardin C, Burgoyne CF, Fortune B. Comparing three different modes of electroretinography in experimental glaucoma: diagnostic performance and correlation to structure. Doc Ophthalmol. 2017 Apr;134(2):111-128. PMCID: PMC5542776.
  • Wilsey LJ, Reynaud J, Cull G, Burgoyne CF, Fortune B. Macular Structure and Function in Nonhuman Primate Experimental Glaucoma. Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1892-900. PMCID: PMC4849889.
  • Wilsey LJ, Fortune B. Electroretinography in glaucoma diagnosis. Curr Opin Ophthalmol. 2016 Mar;27(2):118-24. PMCID: PMC4698880.
  • Parikh A, Mantravadi R, Kozhevnikov D, Roche MA, Ye Y, Owen LJ, Puglisi JL, Abramson JJ, Salama G. Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2. Heart Rhythm. 2012 Jun;9(6):953-60. PMC3335957.
  • Ye Y, Yaeger D, Owen LJ, Escobedo JO, Wang J, Singer JD, Strongin RM, Abramson JJ. Designing calcium release channel inhibitors with enhanced electron donor properties: stabilizing the closed state of ryanodine receptor type 1. Mol Pharmacol. 2012 Jan;81(1):53-62. PMC3250111.

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}